Cargando…

Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview

Advances in imaging have enabled the identification of prostate cancer foci with an initial application to focal dose escalation, with subvolumes created with image intensity thresholds. Through quantitative imaging techniques, correlations between image parameters and tumour characteristics have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Her, Emily Jungmin, Haworth, Annette, Rowshanfarzad, Pejman, Ebert, Martin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226478/
https://www.ncbi.nlm.nih.gov/pubmed/32244821
http://dx.doi.org/10.3390/cancers12040854
_version_ 1783534297574014976
author Her, Emily Jungmin
Haworth, Annette
Rowshanfarzad, Pejman
Ebert, Martin A.
author_facet Her, Emily Jungmin
Haworth, Annette
Rowshanfarzad, Pejman
Ebert, Martin A.
author_sort Her, Emily Jungmin
collection PubMed
description Advances in imaging have enabled the identification of prostate cancer foci with an initial application to focal dose escalation, with subvolumes created with image intensity thresholds. Through quantitative imaging techniques, correlations between image parameters and tumour characteristics have been identified. Mathematical functions are typically used to relate image parameters to prescription dose to improve the clinical relevance of the resulting dose distribution. However, these relationships have remained speculative or invalidated. In contrast, the use of radiobiological models during treatment planning optimisation, termed biological optimisation, has the advantage of directly considering the biological effect of the resulting dose distribution. This has led to an increased interest in the accurate derivation of radiobiological parameters from quantitative imaging to inform the models. This article reviews the progress in treatment planning using image-informed tumour biology, from focal dose escalation to the current trend of individualised biological treatment planning using image-derived radiobiological parameters, with the focus on prostate intensity-modulated radiotherapy (IMRT).
format Online
Article
Text
id pubmed-7226478
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72264782020-05-18 Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview Her, Emily Jungmin Haworth, Annette Rowshanfarzad, Pejman Ebert, Martin A. Cancers (Basel) Review Advances in imaging have enabled the identification of prostate cancer foci with an initial application to focal dose escalation, with subvolumes created with image intensity thresholds. Through quantitative imaging techniques, correlations between image parameters and tumour characteristics have been identified. Mathematical functions are typically used to relate image parameters to prescription dose to improve the clinical relevance of the resulting dose distribution. However, these relationships have remained speculative or invalidated. In contrast, the use of radiobiological models during treatment planning optimisation, termed biological optimisation, has the advantage of directly considering the biological effect of the resulting dose distribution. This has led to an increased interest in the accurate derivation of radiobiological parameters from quantitative imaging to inform the models. This article reviews the progress in treatment planning using image-informed tumour biology, from focal dose escalation to the current trend of individualised biological treatment planning using image-derived radiobiological parameters, with the focus on prostate intensity-modulated radiotherapy (IMRT). MDPI 2020-04-01 /pmc/articles/PMC7226478/ /pubmed/32244821 http://dx.doi.org/10.3390/cancers12040854 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Her, Emily Jungmin
Haworth, Annette
Rowshanfarzad, Pejman
Ebert, Martin A.
Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview
title Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview
title_full Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview
title_fullStr Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview
title_full_unstemmed Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview
title_short Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview
title_sort progress towards patient-specific, spatially-continuous radiobiological dose prescription and planning in prostate cancer imrt: an overview
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226478/
https://www.ncbi.nlm.nih.gov/pubmed/32244821
http://dx.doi.org/10.3390/cancers12040854
work_keys_str_mv AT heremilyjungmin progresstowardspatientspecificspatiallycontinuousradiobiologicaldoseprescriptionandplanninginprostatecancerimrtanoverview
AT haworthannette progresstowardspatientspecificspatiallycontinuousradiobiologicaldoseprescriptionandplanninginprostatecancerimrtanoverview
AT rowshanfarzadpejman progresstowardspatientspecificspatiallycontinuousradiobiologicaldoseprescriptionandplanninginprostatecancerimrtanoverview
AT ebertmartina progresstowardspatientspecificspatiallycontinuousradiobiologicaldoseprescriptionandplanninginprostatecancerimrtanoverview